biote Corp.

Haymaker Acquisition Corp. II (Nasdaq: HYAC), sponsored by Haymaker Sponsor II, LLC, filed a 10-Q quarterly report with the SEC on August 17, 2021, reflecting its standing as a blank-check company with a pending business combination. The SPAC completed its initial public offering in 2020, targeting the healthcare and consumer sectors, and subsequently announced a proposed merger with biote Corp., a hormone optimization company operating in the pellet therapy space. At the time of the filing, the transaction remained in its pre-close phase, awaiting shareholder and regulatory approvals. Sign up on SpacDesk for the full HYAC data profile, including deal timelines and complete filing history.